CNMD vs AORT

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Nov 08, 2026

CNMD

39.8
AI Score
VS
AORT Wins

AORT

49.6
AI Score

Investment Advisor Scores

CNMD

40score
Recommendation
SELL

AORT

50score
Recommendation
HOLD

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric CNMD AORT Winner
Revenue 365.88M 996.09M CNMD
Net Income -20.02M 56.70M CNMD
Gross Margin 63.4% 57.2% AORT
Net Margin -5.5% 5.7% CNMD
Operating Income 370,000 98.96M CNMD
ROE -4.5% 5.3% CNMD
ROA -1.9% 2.5% CNMD
Total Assets 1.04B 2.30B CNMD
Current Ratio 4.42 1.49 AORT
Free Cash Flow -36.43M 91.47M CNMD

Relative Price Performance (Last 90 Days)

CNMD 1M: +12.9% · 3M: +3.5% AORT 1M: -6.1% · 3M: -28.5%

Current Technical Phase

CNMD

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 59

RSI (14): 59.0 · Price: $51.21

AORT

Markdown
Sell / avoid

Price below a falling SMA50 (slope -7.5%), weak momentum, RSI 40

RSI (14): 39.5 · Price: $20.47

Fundamentals Snapshot

Metric CNMD AORT
Market Cap — —
Forward P/E 10.8 39.4
Trailing P/E 21.6 —
Revenue (TTM) — —
Revenue Growth 0.0% 0.1%
Gross Margin 0.5% 0.6%
Operating Margin 0.1% 0.0%
EPS 2.41 -0.36
Dividend Yield — —

Frequently Asked Questions

Based on our detailed analysis, AORT is currently the stronger investment candidate, winning 2 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.